CancerPPD

This page gives details of Query peptides and provides facility to browse the same in CancerPPD database. Please wait while data is being retrieved. For more information see HELP page.

ID	PMID	SEQUENCE	NAME	LENGTH	ACTIVITY
1020	14499271	FLKLLKKLAAKFLPTIICKISYKC	PTP4	24	IC₅₀=18.63 µg/ml
1021	14499271	FLKLLKKLAAKLF	PTP5	13	Not Available
1022	14499271	FLKLLKKLAAKLF	PTP6	13	IC₅₀=13.27 µg/ml
1023	14499271	FLGALFKALSKLL	PTP7	13	IC₅₀=5.01 µg/ml
1024	14499271	FLKLLAGLLKNFA	PTP8	13	IC₅₀=28.9 µg/ml
1109	18617323	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	IC₅₀=12 µg/ml
1110	18617323	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	IC₅₀=15.3 µg/ml
1260	10951191	GLFDIIKKIAESF	Aurein1.2	13	LC₅₀ = 10 µM
1269	10951191	GLFDIVKKVVGAFGSL	Aurein2.5	16	LC₅₀ = 10 µM
1278	10951191	GLFDIAKKVIGVIGSL	Aurein2.6	16	LC₅₀ = 10 µM
1287	10951191	GLFDIVKKIAGHIAGSI	Aurein 3.1	17	LC₅₀ = 10 µM
1296	10951191	GLFDIVKKIAGHIASSI	Aurein 3.2	17	LC₅₀ = 10 µM
1305	10951191	GLFDIVKKIAGHIVSSI	Aurein 3.3	17	LC₅₀ = 10 µM
1408	1708887, 2285300	GIGKFLHAAKKFAKAFVAEIMNS	Magainin B	23	IC₅₀=41 µg/ml
1409	1708887, 2285300	GIGKFLHSAKKFAKAFVAEIMNS	Magainin G	23	IC₅₀=47 µg/ml
1410	1708887, 2285300	AIGKFLHSAKKFGKAFVGEIMNS	Magainin A	23	IC₅₀=53 µg/ml
1411	1708887, 2285300	ALSKALSKALSKALSKALSKALSK	Z44	24	Not Available
1412	1708887, 2285300	ALSKALSKALSKALSKALSKALSK	Z24	24	Not Available
1413	1708887, 2285300	GIGKFLHSAKKFGKAFVGEIMNS	Magainin 2	23	IC₅₀ >200 µg/ml
1714	None	FLGWLFKWAKK	Gaegurin peptides SEQID NO: 1	11	IC₅₀ = 47.69 mM
1720	None	FLKWLFKWAKK	Gaegurin peptides SEQID NO: 2	11	IC₅₀ = 29.1 mM
1726	None	FLGWLFKWAWK	Gaegurin peptides SEQID NO: 3	11	IC₅₀ = 46.51 mM
1732	None	FLWWLFKWAWK	Gaegurin peptides SEQID NO: 4	11	IC₅₀ = 24.32 mM
1746	None	FLGWLFKWAKK	Gaegurin peptides SEQID NO: 1	11	IC₅₀ = 47.69 mM
1754	None	FLKWLFKWAKK	Gaegurin peptides SEQID NO: 2	11	IC₅₀ = 29.1 mM
1762	None	FLGWLFKWAWK	Gaegurin peptides SEQID NO: 3	11	IC₅₀ = 46.51 mM
1770	None	FLWWLFKWAWK	Gaegurin peptides SEQID NO: 4	11	IC₅₀ = 24.32 mM
2524	None	FALALKALKKALKKLKKALKKAL	Hecate AC	23	LD₅₀ =61 µg/ml
2525	None	FALALKALKKALKKLKKALKKAL	Hecate AM	23	LD₅₀ =44 µg/ml
2526	None	MPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG	SB-37 AC	38	Not Available
2527	None	MPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG	SB-37 AM	38	LD₅₀ =630 µg/ml
2528	None	FAKKLAKKLKKLAKKLAKLALAL	SHIVA 10 AC	23	LD₅₀ =83 µg/ml
2529	None	FALAAKALKKLAKKLKKLAKKAL	FLAK01 AM	23	LD₅₀ =41 µg/ml
2530	None	FALALKALKKLLKKLKKLAKKAL	FLAK03 AM	23	LD₅₀ =38 µg/ml
2531	None	FALALKALKKLAKKLKKLAKKAL	FLAK04 AM	23	LD₅₀ =12 µg/ml
2532	None	FALAKLAKKAKAKLKKALKAL	FLAK05 AM	21	LD₅₀ =125 µg/ml
2533	None	FALALKALKKLKKALKKAL	FLAK06 AM	19	LD₅₀ =8 µg/ml
2534	None	FALALKALKKLKKALKKAL	FLAK06 AC	19	LD₅₀ =16 µg/ml
2535	None	FAKKLAKKLKKLAKLALAL	FLAK06 R-AC	19	LD₅₀ =280 µg/ml
2536	None	VALALKALKKALKKLKKALKKAL	KAL V	23	LD₅₀ =65 µg/ml
2537	None	FALALKKALKALKKAL	FLAK 17 AM	16	LD₅₀ =9 µg/ml
2538	None	FAKKLAKLAKKLAKLAL	FLAK 26 AM	17	LD₅₀ =5 µg/ml
2539	None	FAKKLAKLAKKLAKLALAL	FLAK 25 AM	19	LD₅₀ =19 µg/ml
2540	None	FALALKALKKALkkLKKALKKAL	HECATE 2DAc	23	LD₅₀ =64 µg/ml
2541	None	FAKKLAKLAKKLLAL	FLAK43 AM	15	LD₅₀ =10 µg/ml
2542	None	FAKKLAKLAKKALAL	FLAK44 AM	15	LD₅₀ =310 µg/ml
2543	None	FALAKKALKKAKKAL	FLAK62 AM	15	LD₅₀ =435 µg/ml
2544	None	FAKKLAKKLKKLAKLALAK	FLAK 06R-AM	19	LD₅₀ =140 µg/ml
2545	None	GIGKFLKKAKKFGKAFVKILKK	MSI-78 AM	22	LD₅₀ =66 µg/ml
2546	None	FAKLLAKLAKKLL	FLAK50	13	LD₅₀ =12 µg/ml
2547	None	FAKKLAKLALKLAKL	FLAK51	15	LD₅₀ =45 µg/ml
2548	None	FAKKLAKKLAKLAL	FLAK57	14	LD₅₀ =170 µg/ml
2549	None	FAKKLKKLAKLAKKL	FLAK71	15	LD₅₀ =280 µg/ml
2550	None	FAKKALKALKKL	FLAK77	12	LD₅₀ =>1000 µg/ml
2551	None	VAKLLAKLAKKLL	FLAK50V	13	LD₅₀ =32 µg/ml
2552	None	FAKLLAKLAKKL	FLAK50F	12	LD₅₀ =77 µg/ml
2553	None	VAKKLAKLAKKLAKLAL	FLAK26V AM	17	LD₅₀ =54 µg/ml
2554	None	KWKLFKKIGAVLKVL	CAME-15	15	LD₅₀ =40 µg/ml
2555	None	FAKLLAKLAKKAL	FLAK50C	13	LD₅₀ =90 µg/ml
2556	None	FAKLLAKALKKLL	FLAK50D	13	LD₅₀ =47 µg/ml
2557	None	FAKLLKLAAKKLL	FLAK 50E	13	LD₅₀ =435 µg/ml
2558	None	FAKLLAKKLL	FLAK80	10	LD₅₀ =>1000 µg/ml
2559	None	FAKKLAKALL	FLAK81	10	LD₅₀ =>1000 µg/ml
2560	None	FAKKLAKKLL	FLAK82	10	LD₅₀ =81 µg/ml
2561	None	FAKLAKKLL	FLAK83M	9	LD₅₀ =>1000 µg/ml
2562	None	FAKKLAKLAKKLAKLAL	FLAK 26 Ac	17	LD₅₀ =66 µg/ml
2563	None	ILPWKWPWWPWRR	Indolicidin	13	LD₅₀ =290 µg/ml
2564	None	FAKALKALLKALKAL	FLAK 17 C	15	LD₅₀ =46 µg/ml
2565	None	FAKLLAKLAKAKL	FLAK 50H	13	LD₅₀ =470 µg/ml
2566	None	FAKLLAKLAKLKL	FLAK 50G	13	LD₅₀ =170 µg/ml
2567	None	FAKKLAKKLKKLAKKLAKKWKL	SHIVA DERIV P69 + KWKL	22	LD₅₀ =82 µg/ml
2568	None	FAKKLAKKLKKLAKKLAK	Shiva 10(1-18 AC)	18	LD₅₀ =270 µg/ml
2569	None	FAKKLAKKLKKLAKKLAKKWKL	SHIVA 10 PEPTIDE 71 + KWKL	22	LD₅₀ =63 µg/ml
2570	None	KWKLFKKKTKLFKKFAKKLAKKL	CA(1-7)Shiva10(1-16)	23	LD₅₀ =97 µg/ml
2571	None	FAKKLAKKLAKAL	FLAK 54	13	LD₅₀ =660 µg/ml
2572	None	FAKKLAKKLAKLL	FLAK 56	13	LD₅₀ =54 µg/ml
2573	None	FAKKLAKKLAKAAL	FLAK 58	14	LD₅₀ =675 µg/ml
2574	None	FAKKLAKKAKLAKKL	FLAK 72	15	LD₅₀ =>1000 µg/ml
2575	None	FAKKLKKLAKKL	FLAK 75	12	LD₅₀ =>1000 µg/ml
2576	None	KTKLFKKFAKKLAKKLKKLAKKL	SHIVA 10 (1-16) Ac	23	LD₅₀ =28 µg/ml
2577	None	KWKLFKKKTKLFKKFAKKLAKKL	CA(1-7) Shiva10(1-16)-COOH	23	LD₅₀ =170 µg/ml
2578	None	ILPWKWPWWPWRR	Indolocidin-ac	13	LD₅₀ =31 µg/ml
2579	None	FAKALAKLAKKLL	FLAK50B	13	LD₅₀ =83 µg/ml
2580	None	FAKLLAKLAKKAA	FLAK50J	13	LD₅₀ =690 µg/ml
2581	None	FAKLLALALKLKL	FLAK50I	13	Not Available
2582	None	FAKLLAKLAKAKA	FLAK50K	13	LD₅₀ =>1000 µg/ml
2583	None	FAKLLAKLAKAKG	FLAK50L	13	LD₅₀ =>1000 µg/ml
2584	None	FAKKLAKKLKKLAKKLAKLALALKALALKAL	Shiva-11	31	LD₅₀ =52 µg/ml
2585	None	FAKKLAKKLKKLAKKLIGAVLKV	SHIVA 11[(1-16)ME(2-9]-COOH	23	LD₅₀ =28 µg/ml
2586	None	FAKLLAKALKLKL	FLAK 50N	13	LD₅₀ =730 µg/ml
2587	None	FAKLLAKALKKAL	FLAK 50O	13	LD₅₀ =66 µg/ml
2588	None	FAKLLAKALKKL	FLAK 50P	12	LD₅₀ =330 µg/ml
2589	None	KWKLFKKALKKLKKALKKAL	CA(1-& HECATE(11/23)	20	LD₅₀ =18 µg/ml
2590	None	KIAKVALAKLGIGAVLKVLTTGL	PYL-ME	23	Not Available
2591	None	FAKKLAKLAKKL	FLAG26-D1	12	LD₅₀ =>1000 µg/ml
2592	None	MPKEKVFLKIEKMGRNIRN	VISHNU3	19	LD₅₀ =>1000 µg/ml
2593	None	GIGAVLKVLTTGLPALISWIKRKRQQ	MELITTIIN	26	LD₅₀ =13 µg/ml
2594	None	FAKKLAKLAKKLAKAL	FLAK26-D2	16	LD₅₀ =>1000 µg/ml
2595	None	FAKKLLAKALKL	FLAG26-D3	12	LD₅₀ =>1000 µg/ml
2596	None	FAKFLAKFLKKAL	FLAK50 Q1	13	LD₅₀ =11 µg/ml
2597	None	FAKLLFKALKKAL	FLAK50 Q2	13	LD₅₀ =640 µg/ml
2598	None	FAKLLAKFLKKAL	FLAK50 Q3	13	LD₅₀ =240 µg/ml
2599	None	FAKLLAKAFKKAL	FLAK50 Q4	13	LD₅₀ =>1000 µg/ml
2600	None	FAKLFAKAFKKAL	FLAK50 Q5	13	LD₅₀ =>1000 µg/ml
2601	None	FAKLLAKALKKFL	FLAK50 Q6	13	LD₅₀ =330 µg/ml
2602	None	FAKLLAKALKKFAL	FLAK50 Q7	14	LD₅₀ =140 µg/ml
2603	None	FAKLLAKLAKKFAL	FLAK50 Q8	14	LD₅₀ =>1000 µg/ml
2604	None	FAKLFAKLAKKFAL	FLAK50 Q9	14	LD₅₀ =>1000 µg/ml
2605	None	FKLAFKLAKKAFL	FLAK50 Q10	13	LD₅₀ =800 µg/ml
2606	None	FAKLLAKLAK	FLAK50 T1	10	LD₅₀ =>1000 µg/ml
2607	None	FAKLLAKLAKKVL	FLAK50 T2	13	LD₅₀ =10 µg/ml
2608	None	FAKLLAKLAKKIL	FLAK50 T3	13	LD₅₀ =145 µg/ml
2609	None	FAKLLAKLAKKEL	FLAK50 T4	13	LD₅₀ =>1000 µg/ml
2610	None	FAKLLAKLAKKSL	FLAK50 T5	13	LD₅₀ =>1000 µg/ml
2611	None	FAKLA	FLAK90	5	LD₅₀ =>1000 µg/ml
2612	None	FAKLF	FLAK91	5	LD₅₀ =>1000 µg/ml
2613	None	KAKLF	FLAK92	5	LD₅₀ =>1000 µg/ml
2614	None	KWKLF	FLAK93	5	LD₅₀ =>1000 µg/ml
2615	None	FGKGIGKVGKKLL	FLAK50 Z1	13	LD₅₀ =>1000 µg/ml
2616	None	FAFGKGIGKVGKKLL	FLAK50 Z2	15	LD₅₀ =>1000 µg/ml
2617	None	FAKAIAKIAFGKGIGKVGKKLL	FLAK50 Z3	22	LD₅₀ =>1000 µg/ml
2618	None	FAKLWAKLAFGKGIGKVGKKLL	FLAK50 Z4	22	LD₅₀ =310 µg/ml
2619	None	FAKLWAKLAKKL	FLAK50 Z5	12	LD₅₀ =900 µg/ml
2620	None	FAKGVGKVGKKAL	FLAK50 Z6	13	LD₅₀ =>1000 µg/ml
2621	None	FAFGKGIGKIGKKGL	FLAK50 Z7	15	LD₅₀ =>1000 µg/ml
2622	None	FAKIIAKIAKIAKKIL	FLAK50 Z8	16	LD₅₀ =>1000 µg/ml
2623	None	FAFAKIIAKIAKKII	FLAK50 Z9	15	LD₅₀ =>1000 µg/ml
2624	None	FALALKA	FLAK94	7	Not Available
2625	None	KWKLAKKALALL	FLAK93B	12	LD₅₀ =60 µg/ml
2626	None	FAKIIAKIAKKI	FLAK50 Z10	12	LD₅₀ =>1000 µg/ml
2627	None	FALALKALKKAL	FLAK96	12	LD₅₀ =350 µg/ml
2628	None	FALKALKK	FLAK97	8	LD₅₀ =>1000 µg/ml
2629	None	KYKKALKKLAKLL	FLAK98	13	LD₅₀ =440 µg/ml
2630	None	FKRLAKIKVLRLAKIKR	FKRLA	17	LD₅₀ =340 µg/ml
2631	None	FAKLAKKALAKLL	FLAK91B	13	LD₅₀ =>1000 µg/ml
2632	None	KAKLAKKALAKLL	FLAK92B	13	LD₅₀ =>1000 µg/ml
2633	None	KLALKLALKALKAAKLA	FLAK99	17	LD₅₀ =74 µg/ml
2634	None	FAKLLAKLAKK	FLAK50T6	11	LD₅₀ =>1000 µg/ml
2635	None	FAKLLAKLAKKGL	FLAK50T7	13	LD₅₀ =>1000 µg/ml
2636	None	FALKALKKLKKALKKAL	FLAK95	17	LD₅₀ =97 µg/ml
2637	None	VAKLLAKLAKKVL	FLAK50T8	13	LD₅₀ =640 µg/ml
2638	None	YAKLLAKLAKKAL	FLAK50T9	13	Not Available
2639	None	KLLKLLLKLYKKLLKLL	FLAK100-CO2H	17	LD₅₀ =260 µg/ml
2640	None	FAVGLRAIKRALKKLRRGVRKVAKDL	FAGVL	26	LD₅₀ =375 µg/ml
2641	None	KLAKKLAKLAKLAKAL	Modelin-5	16	LD₅₀ =145 µg/ml
2642	None	KLAKKLAKLAKLAKAL	Modelin-5-CO2H	16	LD₅₀ =450 µg/ml
2643	None	FALALKALKKL	FLAK120	9	LD₅₀ =340 µg/ml
2644	None	FALAKALKKAL	FLAK121	11	LD₅₀ =>1000 µg/ml
2645	None	FALALKLAKKAL	FLAK96B	12	LD₅₀ =320 µg/ml
2646	None	FALLKL	FLAK96G	6	LD₅₀ =>1000 µg/ml
2647	None	FALALKALKK	FLAK96F	10	LD₅₀ =>1000 µg/ml
2648	None	FALKALKKAL	FLAK96C	10	LD₅₀ =>1000 µg/ml
2649	None	FALLKALKKAL	FLAK96D	11	LD₅₀ =600 µg/ml
2650	None	KFKKLAKKF	Modelin-8D	9	LD₅₀ =>1000 µg/ml
2651	None	KFKKLAKKW	Modelin-8E	9	LD₅₀ =>1000 µg/ml
2652	None	FALALKALKKA	Flak 96H	11	LD₅₀ =>1000 µg/ml
2653	None	FALLKALLKKAL	Flak 96I	12	LD₅₀ =120 µg/ml
2654	None	FALALKLAKKL	Flak 96J	11	LD₅₀ =>1000 µg/ml
2655	None	LKKLAKLALAF	Flak 96L	11	LD₅₀ =>1000 µg/ml
2656	None	VALALKALKKL	FLAK-120G	11	LD₅₀ =>1000 µg/ml
2657	None	FALALKLKKL	FLAK-120D	10	LD₅₀ =>1000 µg/ml
2658	None	FALALKAKKL	FLAK-120C	10	LD₅₀ =>1000 µg/ml
2659	None	FALA	FLAK-120B	4	LD₅₀ =>1000 µg/ml
2660	None	WALAL	FLAK-120F	5	LD₅₀ =570 µg/ml
2661	None	GIGKFLHAAKKFAKAFVAEIMNS	Magainin2wisc	23	LD₅₀ =45 µg/ml
2662	None	FAKKFAKKFKKFAKKFAKFAFAF	D2A21	23	LD₅₀ =45 µg/ml
2663	None	KKVVFKVKFK	KSL-1	10	LD₅₀ =>1000 µg/ml
2664	None	FKVKFKVKVK	KSL-7	10	LD₅₀ =530 µg/ml
2665	None	LPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG	LSB-37	38	LD₅₀ =370 µg/ml
2666	None	FAKKLAKKLKKLAKKLAKLAKKL	Anubis-2	23	LD₅₀ =66 µg/ml
2810	23000474	RRRRRNWMWC	9R	10	IC₅₀=44 µM
2811	23000474	RRRRRWCMNW	9S1R	10	IC₅₀=26 µM
2812	23000474	RRRRRNWMWC	9R	10	IC₅₀=23 µM
2813	23000474	RRRRRWCMNW	9S1R	10	IC₅₀=9 µM
2814	23000474	RRRRRNWMWC	9R	10	IC₅₀=28 µM
2815	23000474	RRRRRWCMNW	9S1R	10	IC₅₀=8 µM
2845	15634655	ERRP	EGFR-related peptide	4	30% Cell viability at 5 µg/ml
2846	23028527	GLWSKIKEVGKEAAKAAAKAAGKAALGAVSEAV	Adenoregulin	33	GI₅₀ =1.24±0.23 µM
2847	23028527	GLWSKIKEVGKEAAKAAAKAAGKAALGAVSEAV	Adenoregulin	33	GI₅₀ =0.31±0.15 µM
2848	23028527	GLWSKIKEVGKEAAKAAAKAAGKAALGAVSEAV	Adenoregulin	33	GI₅₀ =0.91±0.04 µM
2869	16707464	LKlLKKLlkKLLkLL	D-K6L9	15	LC₅₀=6 µMol/L
2871	16707464	LKlLKKLlkKLLkLL	D-K6L9	15	LC₅₀=3 µMol/L
2911	21849092	KLlLKlLkkLLKlLKKK	Lytik	17	IC₅₀= 15.8 µM
2923	21849092	THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK	Transferrin receptor (TfR)-lytic hybrid peptide	32	IC₅₀= 6.2 µM
3128	23770440	FLGMIPGLIGGLISAFK	TsAP-2	17	IC₅₀ = 13.3 µM
3133	23770440	FLSLIPKLVKKIIKAFK	TsAP-S1	17	IC₅₀ = 2.1 µM
3138	23770440	FLGMIPKLIKKLIKAFK	TsAP-S2	17	IC₅₀ = 1.6 µM
3190	17787026	(K-Aib-C(CH2CO-2'-Pac))3	Dimer of peptide-paclitaxel conjugate	3	IC₅₀ =2.85nM
3193	17787026	(K-Aib-C(CH2CO-2'-Pac))3	Trimer of peptide-paclitaxel conjugate	3	IC₅₀ =3.88nM
3196	17787026	(K-Aib-C(CH2CO-2'-Pac))4	Tetramer of peptide-paclitaxel conjugate	3	IC₅₀ =1.30nM
3230	22644847	FLGWLFKWAWK	GA-W3	11	IC₅₀ =46.51 µM
3237	22644847	FLWWLFKWAWK	GA-W4	11	IC₅₀ =24.32 µM
3244	22644847	FLGWLFKWAKK	GA-K3	11	IC₅₀ =47.69 µM
3251	22644847	FLKWLFKWAKK	GA-K4	11	IC₅₀ =29.10 µM
3731	22644847	FLGWLFKWAWK	GA-W3	11	IC₅₀= 46.51 µM
3738	22644847	FLWWLFKWAWK	GA-W4	11	IC₅₀= 24.32 µM
3745	22644847	FLGWLFKWAKK	GA-K3	11	IC₅₀= 47.69 µM
3752	22644847	FLKWLFKWAKK	GA-K4	11	IC₅₀= 29.10 µM
4037	12631273, 9266696	GLFDVIKKVASVIGGL	Citropin 1.1	16	IC₅₀= 5 M
4046	12631273, 9266696	glfdvikkvasviggl	Citropin 1.1D	16	IC₅₀= 5 M
4055	12631273, 9266696	GLFAVIKKVASVIGGL	3	16	IC₅₀= 6 M
4064	12631273, 9266696	GLFDVIKAVASVIGGL	5	16	IC₅₀= 5 M
4073	12631273, 9266696	GLFDVIKKVAAVIGGL	7	16	IC₅₀= 5 M
4082	12631273, 9266696	GLFDVIKKVASVIKGL	11	16	IC₅₀= 5 M
4091	12631273, 9266696	GLFDVIKKVASVIKKL	13	16	IC₅₀= 5 M
4100	12631273, 9266696	GLFDVIAKVASVIKKL	14	16	IC₅₀= 5 M
4109	12631273, 9266696	GLFAVIKKVASVIKGL	15	16	IC₅₀= 5 M
4118	12631273, 9266696	GLFAVIKKVASVIKKL	16	16	IC₅₀= 5 M
4127	12631273, 9266696	GLFAVIKKVAAVIKKL	17	16	IC₅₀= 5 M
4136	12631273, 9266696	GLFAVIKKVAAVIRRL	18	16	IC₅₀= 5 M
4145	12631273, 9266696	GLFAVIKKVAKVIKKL	19	16	IC₅₀= 5 M
4154	12631273, 9266696	GLFKVIKKVASVIGGL	22	16	IC₅₀= >10 µM
4163	12631273, 9266696	GLFKVIKKVAKVIKKL	23	16	IC₅₀= 5 M
4172	12631273, 9266696	LGGIVSAVKKIVDFLG	retro	16	IC₅₀= >10 µM
4263	None	lKKllKKllKKl	DL6K6	12	LC₅₀>100 µM
4266	None	lKKllKKllKKl	DDA-DL6K6-22	12	LC₅₀<3.125 µM
4269	None	lKKllKKllKKl	MA-DL6K6-23	12	LC₅₀<3.125 µM
4272	None	lKKllKKllKKl	PA-DL6K6-24	12	LC₅₀<3.125 µM
4275	None	lRRllRRllRRl	DL6R6	12	LC₅₀=50 µM
4278	None	DDAlRRllRRllRRl	DDA-DL6R6-25	15	LC₅₀=3.125 µM
4340	None	YHWYGYTPQNVIGGGKLlLKlLkkLLKlLKKK	EB-Lytic	32	IC₅₀= 10 µM
4346	None	YRWYGYTPQNVIGGGKLlLKlLkkLLKlLKKK	EB(H2R)-lytic	32	IC₅₀= 4.8 µM
4618	20964334	KWKWKW	Dex-(KW)3	6	at 10 µM 60% viablity
4673	22885172	GLFGKLIKKFARKAISYAVKKARGKH	ltc2aG11A	26	graph fig 8 A
4675	9492845	2-[[2-(dimethylamino)-3-methylbutanoyl]amino]-N- [3-methoxy-1-[2-[1-methoxy-2-methyl-3-oxo-3-[[2-phenyl- 1-(1,3-thiazol-2-yl)ethyl]amino]propyl]pyrrolidin-1- yl]-5-methyl-1-oxoheptan-4-yl]-N,3-dimethylbutanamide	Dolastatin 10	Not Available	IC₅₀=0.5 nM
5003	24587350	GIGKFLKKAKKFGKAFVKILKK	Pexiganan	22	LC₅₀= 6 at 100 µM
5004	24587350	LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES	LL 37	37	LC₅₀= 27 at 100 µM

CancerPPD :Database of Anticancer peptides and Proteins

Browse Result page of CancerPPD